In addition to its association with hepatitis B and liver cancer, the cGAS–STING signaling pathway has been shown to be activated in alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), and liver fibrosis. The gene discussed is STING1; the disease is metabolic dysfunction-associated steatotic liver disease.